Patient and Physician Perceptions of Prostate-Specific Antigen Testing Among Black Individuals
JAMA Network Open 10.1001/jamanetworkopen.2025.30946September 08, 2025 at 11:00 AM EDT
What are the patient- and physician-level factors that facilitate or impede access to prostate-specific antigen (PSA) testing for prostate cancer screening among Black individuals in the US?This qualitative study interviewing 29 Black men and surveying 63 physicians found that primary care practitioners may not value PSA testing for prostate cancer early detection or appreciate its role in reducing the risk of prostate cancer–related mortality. They may also rely on US Preventive Services Task Force guidelines for PSA testing, which currently do not provide guideline recommendations for screening high-risk groups, including Black individuals.These findings suggest that patients and primary care practitioners need improved access to accurate and evidence-based information regarding prostate cancer risk and PSA testing among Black men.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.